Overview

The World Stroke Organization reports that “stroke has already reached epidemic proportions. Globally1 in 4 adults over the age of 25 will have a stroke in their lifetime. 12.2 million people worldwide will have their first stroke this year, and 6.5 million will die as a result.” Ischemic strokes are the most common type of stroke, with about 87% of all strokes being ischemic strokes. This new volume addresses this epidemic by presenting detailed studies on ischemic injury, with emphasis on the molecular-level mechanisms and the role of signaling pathways in the body, their structure, and their mechanism of action. The book focuses on molecular pharmacology plans and explains the new areas of research on the discovery of therapeutic molecules that can be used for combating this life-threatening disease. The authors discuss stroke occurrence at different stages of life as well as sex-based differences in its treatment. They cover aspects of the clinical treatment and diagnosis of patients with cardiovascular events, including in-depth information on the prevention, evaluation, therapy selection, result projection, and long-term course of the disease in affected patients. They also detail the involvement of platelets, neurotransmitters, renin-angiotensin-aldosterone system, and vitamin D in ischemic injury.

Full Product Details

9781774915400

Table of Contents

Reviews

Author Information

Thakur Gurjeet Singh, PhD, MPharm, has 16 years of experience in industry, research, and teaching. He is currently Dean of the Chitkara College of Pharmacy, Chitkara University, Punjab, India. He is engaged with projects on interception of nicotine, morphine, alcohol dependence, ischemia, diabetic neuropathy and nephropathy toxicology, epilepsy, Alzheimer’s disease, and stem cell research studies. He has attended UGC networking courses and various preclinical and clinical research training programs. A prolific author and researcher, he has many publications and patents to his credit. He has attended national and international conferences and has guided MPharm and PhD students. He is a reviewer for various highly reputed international journals. Dr. Singh is a member secretary of the Committee for the Purpose of Control and Supervision of Experiments on Animals and is the In-Charge of the animal house facility at the Chitkara College of Pharmacy. Heena Khan, PhD, MPharm, has over five years of experience in research. She is working as a Research Fellow at Chitkara University, Punjab, India, where she is engaged with several projects on stroke, diabetes, Alzheimer’s disease, and Parkinson’s disease. She has more than 30 research and review publications to her credit and is a reviewer for several international journals. She has participated and attended several national and international conferences. She is also a member of the International Society for Pharmacoeconomics and Outcomes Research.

Tab Content 6

Countries Available